Drugs / [¹⁸F]MODAG-009
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 0 | NCT07617688 | May 2026 → May 2027 expected | — | MODAG GmbH | Recruiting | No outcome recorded |
| Phase 0 | NCT07640555 | May 2026 → May 2027 expected | Parkinson disease, multiple system atrophy | MODAG GmbH | Recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | [¹⁸F]MODAG-009 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07640555 ↗ |
| Modality | Diagnostic / imaging agent | “PET Imaging” NCT07640555 ↗ |
| Route | Intravenous | “single intravenous (IV) injection” NCT07617688 ↗ |